AEGR

Aegerion Pharmaceuticals, Inc. News Headlines

$21.37
*  
0.42
2%
Get AEGR Alerts
*Delayed - data as of Nov. 21, 2014  -  Find a broker to begin trading AEGR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
The 1 Biotech Stock I'm Definitely Not Buying
10/7/2014 7:35:04 AM - Motley Fool


Bull vs. Bear: Isis Pharmaceuticals, Inc. Stock
9/29/2014 7:47:03 AM - Motley Fool


Following Biotech Stocks After Price Declines Of Greater Than 50%
9/25/2014 4:03:00 PM - Seeking Alpha


Aegerion Resolves FDA's Warning on Juxtapid, Lifts Overhang - Analyst Blog
8/28/2014 4:50:00 PM - Zacks.com


Sector Update: Health Care Stocks Holding On To Small Gains; Aegerion Pharma Rising After Resolving Juxtapid Issues with Regulators
8/27/2014 12:46:38 PM - MT Newswires


Sector Update: Health Care
8/27/2014 12:44:35 PM - MT Newswires


Aegerion Announces Resolution Of Warning Letter For JUXTAPID Capsules
8/27/2014 8:14:00 AM - RTT News


Aegerion Pharmaceuticals Is Still Significantly Overvalued
8/19/2014 9:01:00 AM - Seeking Alpha


The Long And Short Of It: Buy Insys Therapeutics And Sell GW Pharmaceuticals
8/11/2014 12:05:00 PM - Seeking Alpha


The Long And Short Of It: Buy Insys Therapeutics And Sell GW Pharmaceuticals
8/11/2014 10:45:00 AM - Seeking Alpha


The Long And Short Of It: Buy Insys Therapeutics And Sell GW Pharmaceuticals
8/11/2014 9:45:13 AM - SeekingAlpha


Thursday 7/31 Insider Buying Report: AEGR, OCFC
7/31/2014 2:52:28 PM - BNK Invest


Strength Seen in Aegerion Pharmaceuticals (AEGR): Stock Shoots up 16.4% - Tale of the Tape
7/31/2014 7:44:00 AM - Zacks.com


Regeneron's Eylea Gets FDA Nod for Diabetic Macular Edema - Analyst Blog
7/30/2014 6:00:00 PM - Zacks.com


Aegerion Q2 Loss Narrower than Expected, 2014 View Retained - Analyst Blog
7/30/2014 2:15:00 PM - Zacks.com


Sector Update: Health Care Stocks Narrowly Mixed; Aegerion Pharma Climbing After Paring Q2 Net Loss, Crushing Estimates
7/30/2014 12:36:46 PM - MT Newswires


Sector Update: Health Care
7/30/2014 12:27:15 PM - MT Newswires


Vertex Pharmaceuticals Posts Wider Q2 Loss, Maintains View - Analyst Blog
7/30/2014 12:10:00 PM - Zacks.com


Aegerion Pharmaceuticals, Inc. (AEGR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
7/16/2014 7:00:00 AM - Zacks.com


Basket Of Biotech Bargains To Buy And Hold
6/30/2014 4:23:00 PM - Seeking Alpha


5 Stocks Insiders Love, And Why You Should Too
6/16/2014 1:59:00 PM - Seeking Alpha


Wednesday 5/28 Insider Buying Report: AEGR, EGHT
5/28/2014 2:28:38 PM - BNK Invest


Aegerion CEO buys 10,000 shares
5/28/2014 11:19:00 AM - InvestorsObserver


Aegerion And The Orphan Drug Paradox
5/23/2014 6:10:00 AM - Seeking Alpha


Three CEOs Reporting Large Insider Buys
5/22/2014 6:33:46 PM - GuruFocus